Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 25

1.

The development of search filters for adverse effects of surgical interventions in medline and Embase.

Golder S, Wright K, Loke YK.

Health Info Libr J. 2018 Jun;35(2):121-129. doi: 10.1111/hir.12213. Epub 2018 Mar 31. Review.

2.

Important factors in predicting mortality outcome from stroke: findings from the Anglia Stroke Clinical Network Evaluation Study.

Myint PK, O Bachmann M, Loke YK, D Musgrave S, Price GM, Hale R, Metcalf AK, Turner DA, Day DJ, A Warburton E, Potter JF.

Age Ageing. 2017 Jan 28;46(1):83-90. doi: 10.1093/ageing/afw175.

3.

Methodological review: quality of randomized controlled trials in health literacy.

Brainard J, Wilsher SH, Salter C, Loke YK.

BMC Health Serv Res. 2016 Jul 11;16:246. doi: 10.1186/s12913-016-1479-2. Review.

4.

Meta-analysis: Association between hypoglycaemia and serious adverse events in older patients.

Mattishent K, Loke YK.

J Diabetes Complications. 2016 Jul;30(5):811-8. doi: 10.1016/j.jdiacomp.2016.03.018. Epub 2016 Mar 17. Review.

PMID:
27083445
5.

Pioglitazone--when is a prescription drug safe?

Loke YK, Mattishent K.

Nat Rev Urol. 2015 Dec;12(12):655-6. doi: 10.1038/nrurol.2015.237. Epub 2015 Sep 29. No abstract available.

PMID:
26416647
6.

Prognostic Tools for Early Mortality in Hemorrhagic Stroke: Systematic Review and Meta-Analysis.

Mattishent K, Kwok CS, Ashkir L, Pelpola K, Myint PK, Loke YK.

J Clin Neurol. 2015 Oct;11(4):339-48. doi: 10.3988/jcn.2015.11.4.339. Epub 2015 Aug 6.

7.

Impact of Inhaled Corticosteroids on Growth in Children with Asthma: Systematic Review and Meta-Analysis.

Loke YK, Blanco P, Thavarajah M, Wilson AM.

PLoS One. 2015 Jul 20;10(7):e0133428. doi: 10.1371/journal.pone.0133428. eCollection 2015. Review.

8.

If nothing happens, is everything all right? Distinguishing genuine reassurance from a false sense of security.

Loke YK, Mattishent K.

CMAJ. 2015 Jan 6;187(1):15-6. doi: 10.1503/cmaj.141344. Epub 2014 Nov 17. No abstract available.

9.

Bone mineral density and incidence of stroke: European prospective investigation into cancer-norfolk population-based study, systematic review, and meta-analysis.

Myint PK, Clark AB, Kwok CS, Loke YK, Yeong JK, Luben RN, Wareham NJ, Khaw KT.

Stroke. 2014 Feb;45(2):373-82. doi: 10.1161/STROKEAHA.113.002999. Epub 2014 Jan 7. Review.

PMID:
24399373
10.

Prognosis of multi-lobar pneumonia in community-acquired pneumonia: a systematic review and meta-analysis.

Mannu GS, Loke YK, Curtain JP, Pelpola KN, Myint PK.

Eur J Intern Med. 2013 Dec;24(8):857-63. doi: 10.1016/j.ejim.2013.05.001. Epub 2013 Jun 6. Review.

PMID:
23747042
11.

Response to Chandra et al., and Freedberg and Abrams.

Loke YK, Kwok CS.

Am J Gastroenterol. 2013 Feb;108(2):279-80. doi: 10.1038/ajg.2012.397. No abstract available.

PMID:
23381077
12.

Risk of Clostridium difficile infection with acid suppressing drugs and antibiotics: meta-analysis.

Kwok CS, Arthur AK, Anibueze CI, Singh S, Cavallazzi R, Loke YK.

Am J Gastroenterol. 2012 Jul;107(7):1011-9. doi: 10.1038/ajg.2012.108. Epub 2012 Apr 24. Erratum in: Am J Gastroenterol. 2014 Jan;109(1):144.

PMID:
22525304
13.

Failure or success of electronic search strategies to identify adverse effects data.

Golder S, Loke YK.

J Med Libr Assoc. 2012 Apr;100(2):130-4. doi: 10.3163/1536-5050.100.2.012. No abstract available.

14.

No consistent evidence of differential cardiovascular risk amongst proton-pump inhibitors when used with clopidogrel: meta-analysis.

Kwok CS, Jeevanantham V, Dawn B, Loke YK.

Int J Cardiol. 2013 Aug 10;167(3):965-74. doi: 10.1016/j.ijcard.2012.03.085. Epub 2012 Mar 30.

PMID:
22464478
15.

Functional polymorphisms of folate metabolism and response to chemotherapy for colorectal cancer, a systematic review and meta-analysis.

Jennings BA, Kwok CS, Willis G, Matthews V, Wawruch P, Loke YK.

Pharmacogenet Genomics. 2012 Apr;22(4):290-304. doi: 10.1097/FPC.0b013e328351875d.

PMID:
22388795
16.

Inconsistencies surrounding the risk of adverse outcomes with concomitant use of clopidogrel and proton pump inhibitors.

Kwok CS, Loke YK.

Expert Opin Drug Saf. 2012 Mar;11(2):275-84. doi: 10.1517/14740338.2012.657175. Epub 2012 Jan 31. Review.

PMID:
22288498
17.

Effects of proton pump inhibitors on platelet function in patients receiving clopidogrel: a systematic review.

Kwok CS, Loke YK.

Drug Saf. 2012 Feb 1;35(2):127-39. doi: 10.2165/11594900-000000000-00000. Review.

PMID:
22204719
18.

Statins and associated risk of pneumonia: a systematic review and meta-analysis of observational studies.

Kwok CS, Yeong JK, Turner RM, Cavallazzi R, Singh S, Loke YK.

Eur J Clin Pharmacol. 2012 May;68(5):747-55. doi: 10.1007/s00228-011-1159-4. Epub 2011 Nov 15. Review.

PMID:
22083167
19.

Comparative cardiovascular effects of thiazolidinediones: systematic review and meta-analysis of observational studies.

Loke YK, Kwok CS, Singh S.

BMJ. 2011 Mar 17;342:d1309. doi: 10.1136/bmj.d1309. Review.

20.

Meta-analysis: risk of fractures with acid-suppressing medication.

Kwok CS, Yeong JK, Loke YK.

Bone. 2011 Apr 1;48(4):768-76. doi: 10.1016/j.bone.2010.12.015. Epub 2010 Dec 23.

PMID:
21185417
21.

Effects of proton pump inhibitors on adverse gastrointestinal events in patients receiving clopidogrel: systematic review and meta-analysis.

Kwok CS, Nijjar RS, Loke YK.

Drug Saf. 2011 Jan 1;34(1):47-57. doi: 10.2165/11584750-000000000-00000. Review.

PMID:
21047145
22.

Bisphosphonates and atrial fibrillation: systematic review and meta-analysis.

Loke YK, Jeevanantham V, Singh S.

Drug Saf. 2009;32(3):219-28. doi: 10.2165/00002018-200932030-00004. Review.

PMID:
19338379
23.

Case reports of suspected adverse drug reactions--systematic literature survey of follow-up.

Loke YK, Price D, Derry S, Aronson JK.

BMJ. 2006 Feb 11;332(7537):335-9. Epub 2006 Jan 18. Review.

24.

Assessing the benefit-harm balance at the bedside.

Loke YK.

BMJ. 2004 Jul 3;329(7456):7-8. No abstract available.

25.

Supplemental Content

Loading ...
Support Center